Psychedelics Market Update: H1 2025 in Review
Jul 30, 2025 01:15PM PST
Discover what's been driving growth in the psychedelics market, and what may be next for this emerging healthcare sector.
Life Science Investing: World
Whether it is genetics, medical devices, or beyond, get the comprehensive coverage you need to navigate the international life science markets confidently.
Latest Articles
Biotech and Pharma Market Update: Q2 2025 in Review
Life Science Investing NewsJul 24, 2025 01:15PM PST
More Articles
Company Profiles
IVX:AU
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
CDX:AU
Cardiex Limited
Biomarker technologies and digital solutions to address the world’s largest health disorders.
CEO Interviews
More CEO Interviews
life science News
Appendix 4C and Quarterly Activities Report - June 2025
Pharmaceutical InvestingJul 30, 2025 09:30PM PST
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
GeographyJul 29, 2025 02:30AM PST
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
GeographyJul 28, 2025 03:00AM PST
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
GeographyJul 22, 2025 03:00AM PST
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline
SmartNewsJun 29, 2025 08:11PM PST
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
GeographyJun 24, 2025 03:00AM PST
Underwritten Loyalty Option Entitlement Offer Prospectus
Pharmaceutical InvestingJun 22, 2025 05:30PM PST
Editors' Picks
More Editors' Picks
